[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567944":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":26,"locations":32,"responsibleParty":47,"collaborators":10,"id":49,"slug":10,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":63,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":76,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Hospital Universitari Vall d'Hebron Research Institute","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Migraine Patients",null,"Patients, male and female, with Episodic migraine, all ages.",[13],"Diagnostic Test: Saliva test",{"label":15,"type":10,"description":16,"interventionNames":17},"Control group","Male and female without migraine or headache",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DIAGNOSTIC_TEST","Saliva test","Sampling of CGRP in saliva and DNA blood test and sex hormones blood test.",[15,9],[25],"Blood test",[27],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Patricia Pozo-Rosich, MD, PhD","CONTACT","(+34)934893000","ppozo@vhebron.net",[33],{"facility":34,"status":35,"city":36,"state":36,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Vall d'Hebron University Hospital","RECRUITING","Barcelona","08035","Spain",{"type":40,"coordinates":41},"Point",[42,43],2.15899,41.38879,{"lat":43,"lon":42},[46],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100567944",false,"NCT06674772","Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification","Fenotipado Molecular De Pacientes Con Migraña Según Edad Y Sexo a Través De La Cuantificación De CGRP En Saliva Para Realizar Medicina De Precisión: Estudio FAST","FAST","Inclusion Criteria:\n\n* Migraine patients according to ICHD-3 criteria\n* Healthy controls paired to patient age and sex, without headache and without first degree family history of headache.\n\nExclusion Criteria:\n\n* Presence of any major medical or neurological illness.\n* Presence of any salivary gland malfunction.\n* Abuse or dependence to tobacco, alcohol or any drug in the previous 12 months before the enrollment.\n* Active migraine preventive treatment.\n* Pregnant or breastfeeding female.",true,"ALL","6 Years","75 Years",{"count":61,"type":62},440,"ESTIMATED","1 Day","OBSERVATIONAL","Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.",[67,68,69,70,71,72,73,74,75],"Headache (Migraine)","Migraine","Migraine Headache","Migraine with Aura","Migraine Without Aura","Episodic Migraine","Chronic Migraine Headache","Chronic Migraine, Headache","Episodic Migraine Headache",[68,77,78],"CGRP","saliva","2024-11-11",{"date":81,"type":82},"2024-11-13","ACTUAL",{"date":84,"type":82},"2022-11-29",{"date":86,"type":62},"2025-05",{"name":5,"class":6},1]